The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis

di Guevera, Maria Talamo, McColley, Susanna A.
Pubblicato in Expert Opin Drug Saf (2017)

Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis

di McGarry, Meghan E., McColley, Susanna A.
Pubblicato in Ann Am Thorac Soc (2016)

Cystic Fibrosis Patients of Minority Race and Ethnicity Less Likely Eligible for CFTR Modulators Based on CFTR Genotype

di McGarry, Meghan E., McColley, Susanna A.
Pubblicato in Pediatr Pulmonol (2021)

Trichosporon mycotoxinivorans Infection in Patients with Cystic Fibrosis

di Shah, Avani V., McColley, Susanna A., Weil, Diane, Zheng, Xiaotian
Pubblicazione 2014

The Demographics of Adverse Outcomes in Cystic Fibrosis

di McGarry, Meghan E., Williams, Wadsworth A., McColley, Susanna A.
Pubblicato in Pediatr Pulmonol (2019)

Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

di Hauser, Alan R., Jain, Manu, Bar-Meir, Maskit, McColley, Susanna A.
Pubblicazione 2011

The Need for Quality Improvement in Sweat Testing Infants Following Newborn Screening for Cystic Fibrosis

di LeGrys, Vicky A., McColley, Susanna A., Li, Zhanhai, Farrell, Philip M.
Pubblicato in J Pediatr (2010)

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

di Schechter, Michael S., McColley, Susanna A., Silva, Stefanie, Haselkorn, Tmirah, Konstan, Michael W., Wagener, Jeffrey S.
Pubblicazione 2009

Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities

di Lanzkron, Sophie, Sawicki, Gregory S., Hassell, Kathryn L., Konstan, Michael W., Liem, Robert I., McColley, Susanna A.
Pubblicato in J Clin Transl Sci (2019)

Risk Factors for Onset of Persistent Respiratory Symptoms in Children with Cystic Fibrosis

di McColley, Susanna A., Ren, Clement L., Schechter, Michael S., Regelmann, Warren E., Pasta, David J., Konstan, Michael W.
Pubblicazione 2012

AMINOGLYCOSIDE RESISTANCE OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS RESULTS FROM CONVERGENT EVOLUTION IN THE MEXZ GENE

di Prickett, Michelle H, Hauser, Alan R, McColley, Susanna A, Cullina, Joanne, Potter, Eileen, Powers, Cathy, Jain, Manu
Pubblicato in Thorax (2016)

Antibiotic duration and changes in FEV(1) are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

di Espel, Julia C., Palac, Hannah L., Cullina, Joanne F., Clarke, Alexandria P., McColley, Susanna A., Prickett, Michelle H., Jain, Manu
Pubblicato in BMC Pulm Med (2017)

Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis

di Schechter, Michael S., McColley, Susanna A., Regelmann, Warren, Millar, Stefanie J., Pasta, David J., Wagener, Jeffrey S., Konstan, Michael W., Morgan, Wayne J.
Pubblicazione 2011

Efficacy and safety of ivacaftor treatment: randomized trial in subjects with cystic fibrosis who have an R117H-CFTR mutation

di Moss, Richard B., Flume, Patrick A., Elborn, J. Stuart, Cooke, Jon, Rowe, Steven M., McColley, Susanna A., Rubenstein, Ronald C., Higgins, Mark
Pubblicato in Lancet Respir Med (2015)

Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del‐CFTR

di Rowe, Steven M., McColley, Susanna A., Rietschel, Ernst, Li, Xiaolei, Bell, Scott C., Konstan, Michael W., Marigowda, Gautham, Waltz, David, Boyle, Michael P.
Pubblicato in Ann Am Thorac Soc (2017)

Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic Fibrosis

di Jain, Manu, Ramirez, Daniel, Seshadri, Roopa, Cullina, Joanne F., Powers, Catherine A., Schulert, Grant S., Bar-Meir, Maskit, Sullivan, Christine L., McColley, Susanna A., Hauser, Alan R.
Pubblicazione 2004

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

di Trapnell, Bruce C., McColley, Susanna A., Kissner, Dana G., Rolfe, Mark W., Rosen, Jonathan M., McKevitt, Matthew, Moorehead, Lisa, Montgomery, A. Bruce, Geller, David E.
Pubblicazione 2012

Lung Function Decline From Adolescence to Young Adulthood in Cystic Fibrosis

di VandenBranden, Stacy L., McMullen, Ann, Schechter, Michael S., Pasta, David J., Michaelis, Rory L., Konstan, Michael W., Wagener, Jeffrey S., Morgan, Wayne J., McColley, Susanna A.
Pubblicato in Pediatr Pulmonol (2011)

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1

di McColley, Susanna A., Konstan, Michael W., Ramsey, Bonnie W., Elborn, J. Stuart, Boyle, Michael P., Wainwright, Claire E., Waltz, David, Vera-Llonch, Montserrat, Marigowda, Gautham, Jiang, John G., Rubin, Jaime L.
Pubblicato in J Cyst Fibros (2018)

Refining the continuum of CFTR-associated disorders in the era of newborn screening

di Levy, H., Nugent, M., Schneck, K., Stachiw-Hietpas, D., Laxova, A., Lakser, O., Rock, M., Dahmer, M.K., Biller, J., Nasr, S.Z., Baker, M., McColley, S.A., Simpson, P., Farrell, P.M.
Pubblicato in Clin Genet (2016)